Quadrant Capital Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.68M | Sell |
|
|||||
|
2025
Q2 | $8.31M | Buy |
|
|||||
|
2025
Q1 | $7.49M | Buy |
|
|||||
|
2024
Q4 | $3.04M | Sell |
|
|||||
|
2024
Q3 | $4.55M | Buy |
|
|||||
|
2024
Q2 | $5.31M | Buy |
|
|||||
|
2024
Q1 | $4.63M | Buy |
|
|||||
|
2023
Q4 | $3.62M | Buy |
|
|||||
|
2023
Q3 | $2.97M | Buy |
|
|||||
|
2023
Q2 | $2.41M | Sell |
|
|||||
|
2023
Q1 | $2.41M | Buy |
|
|||||
|
2022
Q4 | $1.9M | Buy |
|
|||||
|
2022
Q3 | $1.25M | Buy |
|
|||||
|
2022
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q1 | $1.27M | Buy |
|
|||||
|
2021
Q4 | $1.18M | Buy |
|
|||||
|
2021
Q3 | $911K | Buy |
|
|||||
|
2021
Q2 | $772K | Buy |
|
|||||
|
2021
Q1 | $585K | Buy |
|
|||||
|
2020
Q4 | $528K | Buy |
|
|||||
|
2020
Q3 | $483K | Buy |
|
|||||
|
2020
Q2 | $368K | Sell |
|
|||||
|
2020
Q1 | $1.55M | Buy |
|
|||||
|
2019
Q4 | $1.44M | Buy |
|
|||||
|
2019
Q3 | $1.01M | Buy |
|
|||||
|
2019
Q2 | $874K | Buy |
|
|||||
|
2019
Q1 | $874K | Buy |
|
|||||
|
2018
Q4 | $551K | Buy |
|
|||||
|
2018
Q3 | $231K | Sell |
|
|||||
|
2018
Q2 | $229K | Buy |
|
|||||
|
2018
Q1 | $243K | Hold |
|
|||||
|
2017
Q4 | $263K | Buy |
|
|||||
|
2017
Q3 | $231K | Buy |
|
|||||
|
2017
Q2 | $175K | Buy |
|
|||||
|
2017
Q1 | $77K | Buy |
|
|||||
|
2016
Q4 | $74K | Buy |
|
|||||
|
2016
Q3 | $26K | Sell |
|
|||||
|
2016
Q2 | $78K | Buy |
|
|||||
|
2016
Q1 | $76K | Sell |
|
|||||
|
2015
Q4 | $135K | Sell |
|
|||||
|
2015
Q3 | $166K | Buy |
|
|||||
|
2015
Q2 | $149K | Buy |
|